Not in the current Orange Book— This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
OLAPARIB | A218044 | NATCO PHARMA LIMITED
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
ASTRAZENECA PHARMACEUTICALS LP et al v. NATCO PHARMA LIMITED 11 patentsANDA 218044olaparib | D.N.J. | 2025-01-09 | Terminated 2025-06-06 | — |
| D.N.J. | 2023-02-10 | Terminated 2024-07-12 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.